Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-06-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/hr/article/view/4001 |
_version_ | 1797936656648503296 |
---|---|
author | Urpu Salmenniemi Kari Remes |
author_facet | Urpu Salmenniemi Kari Remes |
author_sort | Urpu Salmenniemi |
collection | DOAJ |
description | Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment. |
first_indexed | 2024-04-10T18:32:43Z |
format | Article |
id | doaj.art-0c46401806664ec998d546b153e5d836 |
institution | Directory Open Access Journal |
issn | 2038-8322 2038-8330 |
language | English |
last_indexed | 2024-04-10T18:32:43Z |
publishDate | 2012-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Hematology Reports |
spelling | doaj.art-0c46401806664ec998d546b153e5d8362023-02-02T02:36:19ZengMDPI AGHematology Reports2038-83222038-83302012-06-0142e13e1310.4081/hr.2012.e132192Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myelomaUrpu Salmenniemi0Kari Remes1Turku University Hospital, Mepartment of MedicineTurku University Hospital, Department of MedicineThrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.http://www.pagepress.org/journals/index.php/hr/article/view/4001Thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome, multiple myeloma |
spellingShingle | Urpu Salmenniemi Kari Remes Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma Hematology Reports Thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome, multiple myeloma |
title | Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma |
title_full | Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma |
title_fullStr | Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma |
title_full_unstemmed | Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma |
title_short | Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma |
title_sort | thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma |
topic | Thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome, multiple myeloma |
url | http://www.pagepress.org/journals/index.php/hr/article/view/4001 |
work_keys_str_mv | AT urpusalmenniemi thromboticmicroangiopathyassociatedwithbortezomibtreatmentinapatientwithrelapsedmultiplemyeloma AT kariremes thromboticmicroangiopathyassociatedwithbortezomibtreatmentinapatientwithrelapsedmultiplemyeloma |